Prevalence of hepatitis B and hepatitis C virus infection in repeatedly transfused thalassemics in a tertiary care hospital in eastern India
DOI:
https://doi.org/10.18203/2320-6012.ijrms20174596Keywords:
HCV, HBV, Pretransfusion screening, ThalassemiaAbstract
Background: Patients of thalassemia who are conventionally treated by a regular transfusion regimen are at a risk of developing transfusion transmissible infections, including hepatitis. The present study was conducted to assess the prevalence of hepatitis B and hepatitis C virus infections among repeatedly transfused thalassemia patients.
Methods: A total of 207 patients of beta-thalassemia, who had received at least 10 transfusions were tested for hepatitis B surface antigen (HBsAg) and anti-HCV antibody using enzyme linked immunosorbant assay (ELISA).
Results: The overall number of anti-hepatitis C antibody seropositive was 51 (24.6%) and that for hepatitis B surface antigen positives was 7 (3.38%). The prevalence rate for hepatitis B surface antigen was in agreement with average national values, but in case of anti-HCV antibodies the prevalence rate values were comparatively much higher.
Conclusions: Stringent measures need to be taken on urgent basis while screening blood for anti-hepatitis C antibody and hepatitis B surface antigen including inclusion of other sensitive assay like nucleic acid test (NAT) as well as better donor recruitment.
Metrics
References
Flint J, Harding RM, Boyce AJ, Clegg JB. The population genetics of the hemoglobinopathies. Bailliere's Clinical Hematol. 1998;11:1-50.
Thalassemia International Federation: Guidelines for the clinical management thalassemia. 2nd edition. 2008.
Borgna-Pignatti C, Galanello R. Thalassemias and related disorders: quantitative disorders of haemoglobin synthesis. In: Wintrobe's Clinical Hematology. Vol 42-11th ed. Philadelphia, Lippincott Williams and Wilkins; 2004:1319-1365.
Prati D. Benefits and complications of regular blood transfusion in patients with beta-thalassemia major. Vox-Sang. 2000;79(3):129-37.
Mollah AH, Nahar N, Siddique MA, Anwar KS, Hassan T, Azam MG. Common transfusion transmitted infectious agents among thalassemic children in Bangladesh. J Health Popul Nutr. 2003;21(1):67-71.
Borgna-Pignatti C, Vergine G, Lombardo T, Cappellini MD, Cianciulli P, Maggio A, et al. Hepatocellular carcinoma in the thalassemia syndromes. Br J Haematol. 2004;124:114-7.
Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, et al. A proposed system for the nomenclature of Hepatitis C viral genotypes. Hepatol. 1994;19:1321-4.
Hissar SS, Goyal A, Kumar M, Pandey C, Suneetha PV, Sood A, et al. Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease. J Med Virol 2006;78:452-8.
Mukhopadhya A. Hepatitis C in India J Biosci. 2008;33:465-73.
William TN, Wonke B, Donohue SM. A study of hepatitis B and C. Prevalence and liver function in multiply transfused thalassemics and their parents. Ind Pediatr. 1992;29(9):1119-24.
Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97-101.
Martin C, Lilian H, Irma E, Ibarra R, Irma H, Fernandez G, et al. Prevalence of HBV infection and risk factors in a rural community of Mexico. Am J Trop Med Hyg. 2001;65(6):759-63.
Burnett R, Francois G, Kew M, Leroux-Loels G, Meheus A, Moosen A, et al. Hepatitis B virus and human immune deficiency virus coinfection in sub Saharan Africa, a call for further investigation. Liver Int. 2005;25(2):201-24.
Sibnarayan Datta. An overview of molecular epidemiology of hepatitis B virus (HBV) in India. Virol J. 2008;5:156.
Al Shayyab M, Baticha A, El Khateeb M. The prevalence of hepatitis B, hepatitis C and human immunodeficiency virus markers in multi-transfusion patients. J Trop Pediatr. 2001;47(4):239-42.
Younus M, Hassan K, Ikram N, Naseem L, Zaheer HA, Khan MF. Hepatitis C Virus Seropositivity in repeatedly transfused thalassemia major patients. Int J Path. 2004;2(1):20-3.
Khaja MN, Munpally SK, Hussain MM, Habeebullah CM. Hepatitis C virus: The Indian scenario. Curr Sci. 2002;83:219-24.
Siddiqui FA, Akhtar K, Sherwani RK, Rehman K, Alam F, Ansari A. Prevalence of Hepatitis C Virus in Aligarh: A Seven Year Experience. Indian J Community Med. 2009;34(3):264-5.
Bhavsar H. Prevalence of HIV, Hepatitis B and Hepatitis C infection in Thalassemia major patients in tertiary care hospital, Gujarat. NJIRM. 2011;2(3):47-50.
Shaharam M. Epidemiology of HBV, HCV, HIV in pts. with beta thalassemia major in Iran a multicentric study. Arch of Int Med. 2006;319-2.
Ansar MM, Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht. J Viral Hepat. 2002;9(5):390-2.
Singh H, Pradhan M, Singh RL, Phadke S, Naik SR, Aggarwal R, et al. High frequency of hepatitis B virus infection in patients with β-thalassemia receiving multiple transfusions. Vox- Sang. 2003;84(4): 292-9.
Narayan S. Microbes and blood transfusion. Indian J Med Microbiol. 2001;19:119-26.
Sen S, Mishra NM, Giri T. AIDS in multi-transfused children with thalassemia. Indian Pediatr. 1993;30:455-60.
Kuhns MC, Busch MP. New strategies for blood donor screening for hepatitis B virus: Nucleic acid testing versus immunoassay methods. Mol Diagn Ther. 2006;10:77-91.
Mathur M, Wanjari K, Turbadkar D. Seroprevalence of HIV, hepatitis C and hepatitis B in multitransfused thalassemics. Ind J Med Microbiol. 2008;26(2):205-6.
Rehman M, Akhtar GN, Qadeer M, Shams T, Usman A, Lodhi Y. Safe blood begins with safe donors. Pak J Med Sci. 2003;19(3):161-8.
Downloads
Published
How to Cite
Issue
Section
